Rezolute, Inc. (RZLT)
NASDAQ: RZLT · Real-Time Price · USD
5.02
+0.23 (4.80%)
At close: Jun 18, 2026, 4:00 PM EDT
5.04
+0.02 (0.40%)
After-hours: Jun 18, 2026, 7:47 PM EDT
Rezolute Market Cap
Rezolute has a market cap or net worth of $524.42 million as of June 18, 2026. Its market cap has increased by 38.74% in one year.
Market Cap
524.42M
Enterprise Value
405.27M
1-Year Change
38.74%
Ranking
Category
Stock Price
$5.02
Market Cap Chart
Since November 10, 2020, Rezolute's market cap has increased from $167.00M to $524.42M, an increase of 214.03%. That is a compound annual growth rate of 22.66%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 17, 2026 | 461.20M | 110.79% |
| Dec 31, 2025 | 218.80M | -22.93% |
| Dec 31, 2024 | 283.90M | 622.39% |
| Dec 29, 2023 | 39.30M | -48.43% |
| Dec 30, 2022 | 76.20M | 3.25% |
| Dec 31, 2021 | 73.80M | -26.27% |
| Dec 31, 2020 | 100.10M | -40.06% |
| Nov 10, 2020 | 167.00M | - |
View and export this data all the way back to 2020. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Gyre Therapeutics | 562.85M |
| MiMedx Group | 548.87M |
| AgomAb Therapeutics NV | 541.97M |
| ProKidney | 539.18M |
| Altimmune | 530.91M |
| Eikon Therapeutics | 526.77M |
| XOMA Royalty | 526.16M |
| Valneva SE | 511.98M |